Share Profile

Abivax SA has been listed on the Paris Stock Exchange since 26 June 2015.

  • ISIN code: FR0012333284
  • Symbol: ABVX
  • ICB Classification: Healthcare 4000/ Biotechnology 4573
  • Market: Euronext Paris-Compartment C
  • Type of Listing: continuous
  • Number of outstanding shares: 10,199,182 as of 30 September 2018
  • Indicies: CAC ALL SHARES, CAC All-Tradable, CAC MID&SMALL, CAC SMALL, CAC Health Care, CAC Pharma & Bio, and Next Biotech
  • Eligible to French PEA PME

Analysts

NIBC:

Dylan van Haaften & Anita Ye

Goetz Partners:

Chris Redhead
  • October 5, 2017: Company Note (English)

LifeSci Capital:

David Sherman & Sam Slutsky
  • May 16, 2017: KOL Series (English)
  • December 7, 2016: KOL Series (English)
  • Septembre 22, 2016: Company Update (English)
  • June 2, 2016: Company Update (English)
  • March 1, 2016: Initiating Coverage (English)

Aurgalys:

Jean-Pierre Loza
  • March 27, 2017: Analyst report (French)
  • January 18, 2016: Analyst report (French)
  • August 31, 2015: Coverage initiation report (French)

Royal Bank of Canada:

Douglas Miehm & Joel Hurren

Investor Contact

Chris Maggos LifeSci Advisors Chris@lifesciadvisors.com +41 79 367 6254